<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Bone and soft tissue sarcomas, tumors of the skin</journal-id><journal-title-group><journal-title xml:lang="en">Bone and soft tissue sarcomas, tumors of the skin</journal-title><trans-title-group xml:lang="ru"><trans-title>Саркомы костей, мягких тканей и опухоли кожи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2219-4614</issn><issn publication-format="electronic">2782-3687</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">230</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL ONCOLOGY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНАЯ ОНКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Content of soluble form of vascular endothelial adhesion molecule type 1 (sVCAM-1) in the serum of patients with bone tumors</article-title><trans-title-group xml:lang="ru"><trans-title>Содержание растворимой формы молекулы адгезии эндотелия сосудов 1-го типа (sVCAM-1) в сыворотке крови больных новообразованиями костей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Babkina</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Бабкина</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Russo</surname><given-names>E. Yu.</given-names></name><name xml:lang="ru"><surname>Руссо</surname><given-names>Е. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Soloviev</surname><given-names>Yu. N.</given-names></name><name xml:lang="ru"><surname>Соловьев</surname><given-names>Ю. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuznetsov</surname><given-names>I. N.</given-names></name><name xml:lang="ru"><surname>Кузнецов</surname><given-names>И. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ten</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Тен</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kushlinsky</surname><given-names>N. E.</given-names></name><name xml:lang="ru"><surname>Кушлинский</surname><given-names>Н. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>biochimia@mtv-net.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aliev</surname><given-names>M. D.</given-names></name><name xml:lang="ru"><surname>Алиев</surname><given-names>М. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Moscow University of Medicine and Dentistry</institution></aff><aff><institution xml:lang="ru">ФПДО ГБОУ ВПО Московский медико-стоматологический университет Минздравсоцразвития РФ</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">Российский онкологический научный центр им. Н.Н. Блохина РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-01-11" publication-format="electronic"><day>11</day><month>01</month><year>2012</year></pub-date><volume>4</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>52</fpage><lpage>54</lpage><history><date date-type="received" iso-8601-date="2022-01-11"><day>11</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, Babkina I.V., Russo E.Y., Soloviev Y.N., Kuznetsov I.N., Ten E.A., Kushlinsky N.E., Aliev M.D.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Бабкина И.В., Руссо Е.Ю., Соловьев Ю.Н., Кузнецов И.Н., Тен Е.А., Кушлинский Н.Е., Алиев М.Д.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">Babkina I.V., Russo E.Y., Soloviev Y.N., Kuznetsov I.N., Ten E.A., Kushlinsky N.E., Aliev M.D.</copyright-holder><copyright-holder xml:lang="ru">Бабкина И.В., Руссо Е.Ю., Соловьев Ю.Н., Кузнецов И.Н., Тен Е.А., Кушлинский Н.Е., Алиев М.Д.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://sarbon.abvpress.ru/jour/article/view/230">https://sarbon.abvpress.ru/jour/article/view/230</self-uri><abstract xml:lang="ru"><p>Представлены результаты сравнительного анализа уровней sVCAM-1 в сыворотке крови практически здоровых людей (n=50), больных злокачественными (n=152) и пограничными (n=14) опухолями костей с учетом основных клинических и морфологических характеристик заболевания. У пациентов с новообразованиями костей среднее содержание sVCAM-1 в сыворотке крови было достоверно выше, чем у практически здоровых людей. Не выявлено различий в содержании sVCAM-1 при пограничных и злокачественных опухолях костей. У пациентов с положительным эффектом от химиотерапевтического лечения, соответствующим 3-4-й степени лечебного патоморфоза опухоли, исходные уровни sVCAM-1 были ниже по сравнению с больными, у которых отметили резистентность к химиотерапии или 1-2-ю степень лечебного патоморфоза.</p></abstract><kwd-group xml:lang="en"><kwd>sVCAM-1</kwd><kwd>sVCAM-1</kwd><kwd>osteosarcoma</kwd><kwd>chondrosarcoma</kwd><kwd>serum</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>остеосаркома</kwd><kwd>хондросаркома</kwd><kwd>сыворотка крови</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Corradi D., Wenger D.E., Bertoni F. et al. Multicentric osteosarcoma: clinicopathologic and radiographic study of 56 cases. Am. J. Clin. Pathol. 2011, v. 136, No. 5. p. 799-807.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Deneva-Koycheva T.I., Vladimirova-Kitova L.G., Angelova E.A., Tsvetkova T.Z. Serum levels of siCAM-1, sVCAM-1, sE-selectin, sP-selectin in healthy Bulgarian people. Folia Med. (Plovdiv). 2011, v. 53, No. 2, p. 22-28.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Eggeman H., Stöblen F., Thill M. et al. Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes. Anticancer Res. 2011, v. 31, No. 8, p. 2617-2622.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Landt S., Wehling M., Heidecke H. et al. Prognostic significance of angiogenic factors in uterine cervical cancer. Anticancer Res. 2011, v. 31, No. 8, p. 2589-2595.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Mantur M., Snarska J., Koper O. et al. Serum sICAM, sVCAM and sE-selectin levels in colorectal cancer patients. Folia Histochem. Cytobiol. 2009, v. 47, No. 4, p. 621-625.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Rutkowski P., Kaminska J., Kowalska M. et al. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis. J. Surg. Oncol. 2003, v. 84, No. 3, p. 154-159.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sampo M., Koivikko M., Taskinen M. et al. Incidence, epidemiology and treatment results of osteosarcoma in Finland -a nationwide population-based study. Acta Oncol. 2011, v. 50, No. 8, p. 1206-1214.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Shariat S.F., Anwuri V.A., Lamb D.J. et al. Association of preoperative plasma levels of VEGF and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy. J. Clin. Oncol. 2004, v. 29, No. 9, p. 1655-1663.</mixed-citation></ref></ref-list></back></article>
